Latest Articles Page 251 of 383
-
Perspective April 25, 2022
P.1-2
J Cell Biol Metab: 4(2): 1-2
Cellular compartments of neuromodulator axon terminals
Author(s): Cowel Elias*
-
Mini Review April 25, 2022
P.1-2
J Cell Biol Metab: 4(2): 1-2
Outline of attention deficit hyperactivity disorder in young children.
Author(s): Fabian Faustus*
-
Commentary April 23, 2022
P.1-2
J Cell Biol Metab: 4(2): 1-2
Activity expected commencement and propagation: Upstream effects on neurotransmission
Author(s): Baadal Roi*
-
Case Report April 29, 2022
P.1-2
J Cell Biol Metab: 4(2): 1-2
Clinical review on Amyotrophic lateral sclerosis and neurodegenerative disorder.
Author(s): Marielia Shira*
-
Commentary April 30, 2022
P.1-2
J Cancer Immunol Ther: 5(2): 1-2
The development and functioning of B- cell lymphocytes in a human body.
Author(s): Erle Douglas*
-
Rapid Communication April 27, 2022
P.1-2
J Cancer Immunol Ther: 5(2): 1-2
Integrative medication in most cancers survivors in current times.
Author(s): Eckhart Tolle*
-
Perspective April 27, 2022
P.1-2
J Cancer Immunol Ther: 5(2): 1-2
Eating regimen and most cancers prevention research from mechanism to implementation.
Author(s): Henri Gordon*
-
Short Communication May 23, 2022
P.1-2
J Cancer Immunol Ther: 5(2): 1-2
Various genes involved in the cause of breast cancer.
Author(s): Trebor Ohl*
-
Mini Review April 23, 2022
P.1-2
J Cancer Immunol Ther: 5(2): 1-2
Knowledge about dangerous factors of breast cancer and its preventions.
Author(s): Stein Riverton*
-
Brief Report April 30, 2022
P.1-4
J Anest Anesthes: 4(2): 1-4
A clinical audit on standards for grading for risk assessment & prophylactic management of postoperative nausea and vomiting.
Author(s): Yilkal Tadesse Desta